DNM1L and cancer: In addition, elevated Drp1 expression and phosphorylation on S616 detected by immunoblotting and immunocytochemical analyses have been linked to cancer, including melanoma, glioblastoma, lung, breast, thyroid, pancreatic, and head and neck cancer (Rehman et al, 2012; Zhao et al, 2013; Ferreira-da-Silva et al, 2015; Kashatus et al, 2015; Serasinghe et al, 2015; Liang et al, 2020; Huang et al, 2022).